Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products. *
Please click to see notes of Issued Shares.Issued Shares (excluding treasury shares)
3,549,571,148 (as at 30 Jun 2025)
Industry
Healthcare - Pharmaceuticals & Biotechnology - Pharmaceuticals Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the . (HSIC)
Industry Classification (CSIC) is provided by China Securities Indexes Co., Ltd. and only available for companies dually listed in Hong Kong and Shanghai. Please see the . (CSIC)
Listing Date
19 Dec 1995
Financial Year Ends
31 Dec 2024
Chairman
Tang Weikun
Principal Office
Unit 3302
The Centre
99 Queen's Road Central
Hong Kong
Place of Incorporation
Bermuda
Listing Category
Primary Listing
Primary Market
Depositary
DR Ratio
Description
Amount Outstanding
-
-
Subscription Rights per Unit
Subscription price/Strike price
Listing Date
The entitlement ratio in general represents the number of warrants required to be exercised into one share or one unit of the underlying asset (subject to any adjustments as may be necessary to reflect any capitalization, rights issue, distribution or the like).Entitlement Ratio
Subscription Period
Underlying Stock Code
Trading Currency